Moleculin Biotech (NASDAQ:MBRX) Stock Rating Lowered by Maxim Group
Moleculin Biotech (NASDAQ:MBRX – Get Free Report) was downgraded by stock analysts at Maxim Group from a “buy” rating to a “hold” rating in a report issued on Wednesday, MarketBeat reports. Separately, StockNews.com started coverage on shares of Moleculin Biotech in a research note on Sunday, February 9th. They set a “sell” rating on the […]
Moleculin Biotech (NASDAQ:MBRX – Get Free Report) was downgraded by stock analysts at Maxim Group from a “buy” rating to a “hold” rating in a report issued on Wednesday, MarketBeat reports. Separately, StockNews.com started coverage on shares of Moleculin Biotech in a research note on Sunday, February 9th. They set a “sell” rating on the […]
